Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Morepen Laboratories Ltd - 500288 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons for trading in Company''s Shares/ Securities, the Trading Window shall remain closed w.e.f, 1st October, 2019 for the purpose of consideration and approval of Financial Results for the quarter and half-year ended 30th September, 2019. The Trading Window shall remain closed till 48 hours after the announcement of the said financial results, when the information becomes generally available.
30-09-2019
Bigul

Morepen Laboratories Ltd - 500288 - Outcome of Board Meeting

 This is in reference to the notice of Extra-Ordinary General Meeting ('EGM') of the members of the company scheduled for 19th October, 2019 for considering, inter-alia, the preferential issue of fully convertible warrants to the promoter group. In light of the SEBI order dated September 24, 2019 w.r.t., issuance of GDR in the year 2003 by the company, the said meeting of the members is put on hold for the time being. The e-voting facility provided by the company to the members through NSDL also therefore withdrawn.
26-09-2019
Bigul

Morepen Laboratories stock falls 17% after SEBI order

 Share price of Morepen Laboratories fell over 17% intraday on Wednesday, after market regulator barred Morepen Laboratories from the capital market for one year for making misleading disclosure about the issuance of global depository receipts (GDRs).
25-09-2019
Bigul

Morepen Laboratories Ltd - 500288 - Clarification On The SEBI''s Order

 This is in furtherance to our letter dated 24th September, 2019, w.r.t., order passed by Securities and Exchange Board of India ('SEBI') in the matter of issuance of Global Depository Receipts ('GDR') by the Company, it is hereby clarified that the said matter was pertaining to the year 2003 which has been finally settled by the SEBI today. Further, there is no impact on the existing securities listed with the Stock Exchanges as well as no financial implications on the business operation of the Company, of the said order. Additionally, with reference to the ongoing preferential issue of fully convertible warrants (to be converted within 18 months), the company is seeking guidance regarding implication of the SEBI's order and process to be followed to complete the said preferential issue of warrants.
24-09-2019
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

 Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, this is to inform you that SEBI vide its order no. WTM/ AB / EFD-1/ DRA-1/21/2019-20 dated September 24, 2019, in the matter of issuance of Global Depository Receipts by the Company, wherein, SEBI has directed, inter-alia, prohibition on securities market's access and restraining from buying, selling or otherwise dealing in the securities, either directly or indirectly or in any other manner whatsoever, for a period of one year, to the Company. In this regard, the Company is seeking advice for pursuing suitable remedies including filing of appeal before the appropriate forum.
24-09-2019
Bigul

Morepen Laboratories Ltd - 500288 - Notice Of Extra Ordinary General Meeting

 Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed notice of the Extra-Ordinary General Meeting ('EGM') of the members of the Morepen Laboratories Limited (the 'Company') scheduled to be held on Saturday, October 19, 2019 at 10.00 A.M. (I.S.T.) at the registered office of the Company at Morepen Village, Nalagarh Road, Near Baddi, Distt. Solan, Himachal Pradesh - 173 205.
24-09-2019
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Preferential Issue

 This is to inform you that the Board of Directors of the Company, in their meeting held on Thursday, 19th September, 2019 subject to approval of members of the Company, considered and approved the issue and allotment in aggregate up-to 3,70,00,000 Warrants for an aggregate amount of up-to Rs. 74,00,00,000/- (Rupees Seventy-Four Crore Only), convertible into 3,70,00,000 Equity Shares of Rs. 2/- (Rupees Two Only) each, at a price not less than the price determined in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 ('ICDR Regulations') to promoter group entity(ies) on a preferential basis.
19-09-2019
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Outcome of Board Meeting

 Please find attached outcome of Board Meeting held on Thursday, 19th September, 2019 (Timings: Meeting commenced at 04.00 p.m. and concluded at 04.40 p.m.).
19-09-2019
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Considering And Approving Proposal For Raising Of Funds

 MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2019 ,inter alia, to consider and approve proposal for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue of equity shares/ warrants/ fully or partly convertible instruments to public, investors, including institutions, promoters, promoter group and/or other entities, subject to such regulatory and statutory approvals as may be required including approval of the members of the Company.
16-09-2019
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Morepen Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
14-09-2019
Next Page
Close

Let's Open Free Demat Account